Skip to main content
TAK logo
TAK
(NYSE)
Takeda Pharmaceutical Company Limited
$16.82-- (--)
Loading... - Market loading

Takeda Pharmaceutical Company (TAK) Stock Price & Financial Analysis

Takeda Pharmaceutical Company Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$16.69 - $16.85
52-Week High$18.90
52-Week Low$12.99
Open$16.71
Volume3.51M
Average Volume (3M)3.23M
Market Cap53.92B
Shares Outstanding3.21B
P/E Ratio (TTM)45.69
Forward P/E25.40
Price to Sales (P/S)1.94
Price to Book (P/B)1.13
EV/EBITDA10.04
Revenue (TTM)27.78B
Net Income (TTM)1.18B
Free Cash Flow (TTM)4.96B
EPS (TTM)$0.37
Profit Margin4.25%
Operating Margin13.11%
Return on Equity (ROE)2.47%
Debt to Equity0.63
50-Day MA$16.18
200-Day MA$16.18
52-Week Change14.11%
Annual Dividend$0.97
Dividend Yield5.76%
Payout Ratio200.00%
Last Dividend Ex-DateMar 31, 2027

Frequently Asked Questions About Takeda Pharmaceutical Company

What is the current stock price for TAK?

As of the latest trading session, TAK stock trades at $16.82. The 52-week range is $12.99–$18.90, with a day range of $16.68–$16.84.

What is the P/E ratio for TAK?

Takeda Pharmaceutical Company's trailing P/E ratio is 45.7, meaning investors pay $45.7 for every $1 of annual earnings. The forward P/E is 25.4, reflecting analyst expectations for future earnings. Takeda Pharmaceutical Company operates in the Healthcare sector.

Does TAK pay dividends?

Yes, Takeda Pharmaceutical Company pays a 5.76% annual dividend yield ($0.97 per share). The payout ratio is 200.0%. The last ex-dividend date was 2027-03-31.

What do analysts recommend for TAK?

Based on 1 analyst, the consensus for TAK is Buy.

What is the market cap of TAK?

Takeda Pharmaceutical Company's market capitalization is $53.92B, classifying it as a large-cap company. Takeda Pharmaceutical Company operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.